BioWorld Science

Sep. 3, 2013

View Archived Issues

HDL mimetic peptide exerts cardioprotective activity and reduces atherosclerosis

Read More

Pneumonia case accrual completed for CAPiTA study of Prevenar 13

Read More

Seattle Genetics patents new monoclonal antibodies

Read More

New IL-1 beta antibodies disclosed by researchers in Singapore

Read More

New NIK inhibitors patented by Roche and Genentech

Read More

Favorable phase I trial results reported for novel anti-PSCK9 monoclonal antibody

Read More

BioTime cleared to begin human studies with Renevia

Read More

South African and Swiss teams claim new agents for malaria

Read More

U.S. and Hong Kong researchers disclose novel polypeptides for muscle disorders

Read More

Redbiotec and TeselaGen to collaborate on Herpes virus vaccine library

Read More

Sinupret dry extract demonstrates antiviral and anti-inflammatory activity

Read More

Astellas and MSD sign copromotion agreement for ipragliflozin in Japan

Read More

Heidelberg Pharma and Roche sign license agreement for antibody-targeted amanitin conjugates

Read More

U.K.'s NICE recommends NHS reimbursement for Jetrea

Read More

Benefit seen with ATX-MS-1467 in phase I multiple sclerosis trial

Read More

Susceptibility loci for hypertension identified in Japanese subjects

Read More

Polymorphism on chromosome 9p21 linked to prognosis after myocardial infarction

Read More

University of Warwick researcher wins drug discovery award from Domainex

Read More

Swissmedic opposes approval of Vitaros

Read More

Akorn to acquire Hi-Tech Pharmacal

Read More

World Health Organization prequalifies Menomune meningococcal vaccine

Read More

InVivo Therapeutics outlines development plan for spinal cord injury program

Read More

Initiation of phase I trial of PF-06263507 triggers milestone payment

Read More

Presidio Pharmaceuticals begins phase I hepatitis C study

Read More